These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34671038)

  • 1. Structural and functional analysis of target recognition by the lymphocyte adaptor protein LNK.
    Morris R; Zhang Y; Ellyard JI; Vinuesa CG; Murphy JM; Laktyushin A; Kershaw NJ; Babon JJ
    Nat Commun; 2021 Oct; 12(1):6110. PubMed ID: 34671038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptor protein Lnk associates with Tyr(568) in c-Kit.
    Gueller S; Gery S; Nowak V; Liu L; Serve H; Koeffler HP
    Biochem J; 2008 Oct; 415(2):241-5. PubMed ID: 18588518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS.
    Hu J; Hubbard SR
    J Mol Biol; 2006 Aug; 361(1):69-79. PubMed ID: 16824542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.
    Baran-Marszak F; Magdoud H; Desterke C; Alvarado A; Roger C; Harel S; Mazoyer E; Cassinat B; Chevret S; Tonetti C; Giraudier S; Fenaux P; Cymbalista F; Varin-Blank N; Le Bousse-Kerdilès MC; Kiladjian JJ; Velazquez L
    Blood; 2010 Dec; 116(26):5961-71. PubMed ID: 20870899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
    Hu J; Hubbard SR
    J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of APS and SH2-B on insulin receptor signalling.
    Ahmed Z; Pillay TS
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):529-34. PubMed ID: 11498022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.
    Gery S; Cao Q; Gueller S; Xing H; Tefferi A; Koeffler HP
    J Leukoc Biol; 2009 Jun; 85(6):957-65. PubMed ID: 19293402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular regulation of Janus kinase (JAK) activation.
    Babon JJ; Lucet IS; Murphy JM; Nicola NA; Varghese LN
    Biochem J; 2014 Aug; 462(1):1-13. PubMed ID: 25057888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.
    Koren-Michowitz M; Gery S; Tabayashi T; Lin D; Alvarez R; Nagler A; Koeffler HP
    Br J Haematol; 2013 Jun; 161(6):811-20. PubMed ID: 23590807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.
    Kurzer JH; Saharinen P; Silvennoinen O; Carter-Su C
    Mol Cell Biol; 2006 Sep; 26(17):6381-94. PubMed ID: 16914724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.
    Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L
    Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins.
    Iseki M; Takaki S; Takatsu K
    Biochem Biophys Res Commun; 2000 May; 272(1):45-54. PubMed ID: 10872802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the adaptor protein Lnk in leukemia cells.
    Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
    Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3.
    Lin DC; Yin T; Koren-Michowitz M; Ding LW; Gueller S; Gery S; Tabayashi T; Bergholz U; Kazi JU; Rönnstrand L; Stocking C; Koeffler HP
    Blood; 2012 Oct; 120(16):3310-7. PubMed ID: 22942183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Drosophila SH2B family adaptor Lnk acts in parallel to chico in the insulin signaling pathway.
    Werz C; Köhler K; Hafen E; Stocker H
    PLoS Genet; 2009 Aug; 5(8):e1000596. PubMed ID: 19680438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders.
    Gery S; Gueller S; Chumakova K; Kawamata N; Liu L; Koeffler HP
    Blood; 2007 Nov; 110(9):3360-4. PubMed ID: 17693582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.
    Oh ST; Simonds EF; Jones C; Hale MB; Goltsev Y; Gibbs KD; Merker JD; Zehnder JL; Nolan GP; Gotlib J
    Blood; 2010 Aug; 116(6):988-92. PubMed ID: 20404132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.